Evaluation of anti-obesity activity of duloxetine in comparison with sibutramine along with its anti-depressant activity: an experimental study in obese rats

Author： Chudasama H.P.   Bhatt P.A.  

Publisher： NRC Research Press

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.87, Iss.11, 2009-11, pp. : 900-907

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sibutramine: current status as an anti-obesity drug and its future perspectives

By Sharma Bikash   Henderson David C  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 12, 2008-08 ,pp. : 2161-2173

Informa Healthcare

Access to resources Recommend Favorite

Safety Assessment of an Anti-Obesity Drug (Sibutramine): A Retrospective Cohort Study

By Tyczynski Jerzy E.  

Drug Safety, Vol. 35, Iss. 8, 2012-08 ,pp. : 629-644

Adis International

Access to resources Recommend Favorite

The discovery and status of sibutramine as an anti-obesity drug

By Luque C.A.   Rey J.A.  

European Journal of Pharmacology, Vol. 440, Iss. 2, 2002-04 ,pp. : 119-128

Elsevier

Access to resources Recommend Favorite

Anti-Depressant

By  

Current Bioactive Compounds, Vol. 2, Iss. 3, 2006-09 ,pp. : 383-383

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Depressant

By  

Current Bioactive Compounds, Vol. 1, Iss. 3, 2005-12 ,pp. : 330-331

Bentham Science Publishers

Access to resources Recommend Favorite